炎症性肠病的癌变预防及氨基水杨酸类制剂的潜在化学预防作用
被引量:3
摘要
虽然炎症性肠病(IBD)最终发展为结直肠癌的概率较低,但IBD相关性结直肠癌一直被认为是最令人担忧的并发症。近年来,该领域进展颇多,如确定了癌变的危险因素,癌症预防相关研究的证据日益增多。目前认为IBD发展为结直肠癌的最大危险因素是疾病持续时间,成功的预防策略应包括对这些远期结局进行早期干预。本文旨在综述该领域的最新进展。
出处
《中华消化杂志》
CAS
CSCD
北大核心
2008年第12期802-806,共5页
Chinese Journal of Digestion
参考文献12
-
1Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 2001,48 : 526-535.
-
2Rutter MD, Saunders BP, Wilkinson KH, et ai. Thirty-year analysis of a colonoseopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology, 2006, 130: 1030- 1038.
-
3Velayos FS, Loftus EVJr. Jess T, et al. Predictive and protective factors associated with eolorectal cancer in ulcerative colitis: A case-control study. Gastroenterology, 2006,130: 1941-1949.
-
4Gupta RB, Harpaz N, hzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology, 2007,133 : 1099-1105.
-
5Rubin DT, Huo D, Rothe JA, et al. Increased inflammatory activity is an independent risk factor for dysplasia and colorectal cancer in ulcerative colitis: a case control analysis with blinded prospective pathology review. Gastroenterology, 2006,130: A2.
-
6Nourani S, Huo DZ. Strum W, et al. W1229 5-ASA therapy and a lower inflammatory score in chronic ulcerative colitis are associated with a decreased risk of dysptasia and colorectal cancer. Gastroenterology, 2008, 134: A660.
-
7Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn's colitis: a case control study. Inflamm Bowel Dis, 2006, 12:491-496.
-
8Smith T, Swaroop P. Indications for proctocolectomy and surgical outcomes in patients with inflammatory bowel disease and primary sclerosing cholangitis. Am J Gastroenterol, 2006,101:S457-S458.
-
9Tang J, Kucera G, Sharif O, et al. Mesalamine protects against colorectal cancer in inflammatory bowel disease. Am J Gastroenterol, 2007,102 : S477.
-
10van Staa TP, Card T, l.ogan RF, et al. 5 Aminosalieylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut, 2005,54 : 1573-1578.
同被引文献24
-
1顾清,杨正兵.克罗恩病诊治进展[J].现代临床医学,2007,33(3):222-226. 被引量:5
-
2陈治水,危北海,张万岱.溃疡性结肠炎中西医结合诊治方案(草案)[J].中国中西医结合杂志,2004,24(11):1052-1055. 被引量:178
-
3郑家驹.炎症性肠病药物治疗[J].中华消化杂志,2005,25(11):700-701. 被引量:15
-
4郑家驹.炎症性肠病药物治疗进展[J].胃肠病学和肝病学杂志,2006,15(4):347-349. 被引量:4
-
5夏冰.重视对溃疡性结肠炎规范化的临床诊断与治疗[J].临床消化病杂志,2007,19(1):3-3. 被引量:24
-
6巫协宁,刘爱群.克罗恩病肠壁纤维化的检测、意义和成因[J].中华消化杂志,2007,27(3):210-211. 被引量:8
-
7郑家驹,褚行琦,史肖华,周春立,王毓明.硫唑嘌呤维持克罗恩病临床缓解的疗效与安全性[J].中华消化杂志,2007,27(5):299-302. 被引量:6
-
8郑家驹,沈必武,王毓明.硫唑嘌呤与5-氨基水杨酸制剂合用致严重白细胞减少症[J].中华消化杂志,2007,27(6):428-429. 被引量:4
-
9中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1018
-
10Renato Caviglia,Mentore Ribolsi,Marina Rizzi,Sara Emerenziani,Maria Laura Annunziata,Michele Cicala.Maintenance of remission with infliximab in inflammatory bowel disease: Effi cacy and safety long-term follow-up[J].World Journal of Gastroenterology,2007,13(39):5238-5244. 被引量:14
二级引证文献5
-
1巫协宁.炎症性肠病的中西医结合治疗[J].医学新知,2011,21(1):2-5. 被引量:5
-
2何家鸣,陈延.克罗恩病的中医研究进展[J].中医药学报,2012,40(4):141-144. 被引量:15
-
3巫协宁.一些疑难、重症消化病的个人治疗经验[J].中华消化杂志,2014,34(7):492-494. 被引量:2
-
4巫协宁.克罗恩病的治疗策略和机制[J].国际消化病杂志,2017,37(5):306-310. 被引量:7
-
5栗梦晓,赵文霞.克罗恩病病因病机探析[J].山东中医药大学学报,2020,44(4):396-399. 被引量:21
-
1倪颖梦,时国朝.吸入糖皮质激素对COPD患者肺癌的预防作用[J].中国呼吸与危重监护杂志,2010,9(3):326-328. 被引量:3
-
2陈书长.三级预防可以科学防癌[J].健康指南(中老年),2014(5):44-46.
-
3李瑜元.干细胞移植治疗炎症性肠病[J].中华医学杂志,2008,88(44):3097-3098.
-
4戴映(综述),潘跃银(综述),陈振东(审校).肥胖与癌症预防的关系[J].中外医学研究,2010,8(4):64-66.
-
5卫菊,王椿.急性髓性白血病治疗指南[J].世界临床药物,2004,25(8):459-464. 被引量:7
-
6瞄准肺癌[J].经济导报(医药技术),2006(3):30-31.
-
7张黎明,刘玉兰.溃疡性结肠炎复发因素Cox回归分析[J].中国实用内科杂志,2010,30(4):346-347. 被引量:5
-
8开心果能防肺癌[J].食品与健康,2010(1):4-4.
-
9袁耀宗,孙菁.生物药物治疗炎症性肠病新进展[J].国外医学(消化系疾病分册),2005,25(6):335-337.
-
10孟文玉.慢性萎缩性胃炎的治疗方法与癌变预防[J].大家健康(学术版),2014(24):108-108. 被引量:1